Laboratory acquired infection with recombinant Vaccinia virus containing an immunomodulating construct

Journal of Investigative Dermatology

Volumn 120, Issue 3, 2003, Pages 356-358

  Mempel, Martin ^a   Isa, Gisela ^b   Klugbauer, Norbert ^c   Meyer, Hermann ^d   Wildi, Gregor ^a   Ring, Johannes ^a   Hofmann, Franz ^c   Hofmann, Heidelore ^a,e,f  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Tiergesundheitsdienst Grub   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d Sanitatsakademie der Bundeswehr   (Germany)

^e Dermatol/Allergologie B   (Germany)

^f Klin Poliklin F Dermatol A   (Germany)

Author keywords

Cytohesin 1 gene; Vaccination; Vaccinia virus

Indexed keywords

CYTOHESIN 1; INTERCELLULAR ADHESION MOLECULE 1; POVIDONE IODINE;

ADULT; ARTICLE; CASE REPORT; CELL CULTURE; CLINICAL FEATURE; ELECTRON MICROSCOPY; GENE INACTIVATION; HUMAN; HUMAN TISSUE; INFECTION RISK; LABORATORY; LEUKOCYTE ADHERENCE; MALE; MEDICAL EXAMINATION; PARAPOXVIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SKIN BIOPSY; SKIN INFECTION; SKIN MANIFESTATION; VACCINATION; VACCINIA; VACCINIA VIRUS; VIRUS GENE; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS NEUTRALIZATION; WORKER;

EID: 0344806942     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2003.12074.x     Document Type: Article

References (16)

1. ACIP: Vaccinia (smallpox) vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mortal Weekly Rep 50:1-25, 2001
2. Cohen J: Bioterrorism. Smallpox vaccinations: How much protection remains? Science 294:985, 2001
3. Czerny CP, Wagner K, Gessler K, Mayr A, Kaaden OR: A monoclonal blocking-ELISA for detection of orthopoxvirus antibodies in feline sera. Vet Microbiol 52:185-200, 1996
4. De Clercq E: Cidofovir in the treatment of poxvirus infections. Antiviral Res 55:1-13, 2002
5. Demkowicz WE Jr, Littaua RA, Wang J, Ennis FA: Human cytotoxic T-cell memory: Long-lived responses to vaccinia virus. J Virol 70:2627-2631, 1996
6. Ennis FA, Cruz J, Demkowicz WE Jr, Rothman AL, McClain DJ: Primary induction of human CD8 + cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination. J Infect Dis 185:1657-1659, 2002
7. Geiger C, Nagel W, Boehm T, et al: Cytohesin-1 regulates beta-2 integrin-mediated adhesion through both ARF-GEF function and interaction with LFA-1. EMBO J 19:2525-2536, 2000
8. Isaacs SN: Critical evaluation of smallpox vaccination for laboratory workers. Occup Environ Med 59:573-574, 2002
9. Kolanus W, Nagel W, Schiller B, Zeitlmann L, Godar S, Stockinger H, Seed B: Alpha L beta 2 integrin/LFA-1 binding to ICAM-1 induced by cytohesin-1, a cytoplasmic regulatory molecule Cell 86:233-242, 1996
10. Meyer H, Pfeffer M, Rziha HJ: Sequence alterations within and downstream of the A-type inclusion protein genes allow a differentiation of orthopoxvirus species by polymerase chain reaction. J Gen Virol 75:1975-1981, 1994
11. Moss B: Genetically engineered poxviruses for recombinant gene expression, vaccination and safety. PNAS 93:11341-11348, 1996
12. Openshaw PJ, Alwan WH, Cherrie AH, Record FM: Accidental infection of laboratory worker with recombinant vaccinia virus. Lancet 338:459, 1991
13. Pfeffer M, Meyer H,Wernery U, Kaaden OR: Comparison of camelpox viruses isolated in Dubai. Vet Microbiol 49:135-146, 1996
14. Rupprecht CE, Blass L, Smith K, et al: Human infection due to recombinant vaccinia-rabies glycoprotein virus. N Engl J Med 345:582-586, 2001
15. Thomas I, Brochier B, Languet B, et al: Primary multiplication site of the vaccinia-rabies glycoprotein recombinant virus administerd to foxes by the oral route. J Gen Virol 71:37-42, 1990
16. Williams NR, Cooper BM: Counselling of workers handling vaccinia virus. Occup Med (Lond) 43:125-127, 1993